Tapewire

Nasdaq · USD

RCKT

ROCKET PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
5627
SEC CIK
0001281895
Parsed reports
343

Last 12 months

Inside the activity.

1 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202610
Feb 202606
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202606
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 17, 2023 Filed May 19, 2023 20:05 UTC
Shah GauravDirector · CEO
SaleCommon Stock 4,122 $21.38 $88,107.75
Disclosure

SEC source: 0001140361-23-025742 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 521,642

F1 · security: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document
May 14, 2023 Filed May 17, 2023 00:01 UTC
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 725 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-025132 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,078

Underlying: Common Stock · 725 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
May 14, 2023 Filed May 17, 2023 00:01 UTC
Militello JohnSee Remarks
Exercise / conversionCommon Stock 725 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-025132 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
May 14, 2023 Filed May 17, 2023 00:04 UTC
Shah GauravDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 7,979 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-025133 · form4.xml · derivative · entry 4

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,856

Underlying: Common Stock · 7,979 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
May 14, 2023 Filed May 17, 2023 00:04 UTC
Shah GauravDirector · CEO
Exercise / conversionCommon Stock 7,979 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-025133 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 525,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
May 14, 2023 Filed May 16, 2023 23:57 UTC
Patel KinnariSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 3,989 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-025131 · form4.xml · derivative · entry 4

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,982

Underlying: Common Stock · 3,989 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
May 14, 2023 Filed May 16, 2023 23:57 UTC
Patel KinnariSee Remarks
Exercise / conversionCommon Stock 3,989 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-025131 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,323

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 22:33 UTC
Militello JohnSee Remarks
SaleCommon Stock 2,342 $18.65 $43,678.30
Disclosure

SEC source: 0001140361-23-020312 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,636

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs received by the Reporting Person.

F2 · price: This transaction was executed in multiple brokered trades at prices ranging from $18.55 to $18.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 18, 2023 Filed Apr 20, 2023 22:34 UTC
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 6,364 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-019447 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,670

Underlying: Common Stock · 6,364 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
April 18, 2023 Filed Apr 20, 2023 22:34 UTC
Militello JohnSee Remarks
Exercise / conversionCommon Stock 6,364 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-019447 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,978

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
April 04, 2023 Filed Apr 12, 2023 23:00 UTC
White Mark AndrewChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 57,739 $0.00 Strike: $17.41 $0.00
Disclosure

SEC source: 0001140361-23-018047 · form4.xml · derivative · entry 2

White Mark Andrew · CIK 0001973240 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,739

Underlying: Common Stock · 57,739 shares

Expires 2033-04-04

F2 · derivative.exercise_date: This option represents a right to purchase a total of 57,739 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on April 4, 2024, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

Read SEC document
April 04, 2023 Filed Apr 12, 2023 23:00 UTC
White Mark AndrewChief Medical Officer
GrantCommon Stock, par value $0.01 76,662 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-018047 · form4.xml · nonDerivative · entry 1

White Mark Andrew · CIK 0001973240 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,662

F1 · shares: Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 4, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F1 · balance_after: Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 4, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 19:28 UTC SaleCommon Stock 3,557 $19.06 $67,796.42
Disclosure

SEC source: 0001140361-23-008104 · form4.xml · nonDerivative · entry 1

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,546

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F2 · price: This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2023 Filed Feb 23, 2023 00:28 UTC
Militello JohnSee Remarks
SaleCommon Stock 1,244 $19.06 $23,710.64
Disclosure

SEC source: 0001140361-23-008103 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,614

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F2 · price: This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2023 Filed Feb 23, 2023 00:27 UTC
Shah GauravDirector · CEO
SaleCommon Stock 12,194 $19.06 $232,417.64
Disclosure

SEC source: 0001140361-23-008102 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 536,885

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F2 · price: This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2023 Filed Oct 20, 2023 22:37 UTC Amendment
Militello JohnSee Remarks
SaleCommon Stock 1,076 $19.06 $20,508.56
Disclosure

SEC source: 0001140361-23-049079 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,782

F1 · security: This Form 4 corrects an error on the original Form 4 filed on February 22, 2023. The original Form 4 stated that the Reporting Person sold 1,244 shares of the Issuer's common stock to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. The Reporting Person sold 1,076 shares of the Issuer's common stock on February 17, 2023 to cover tax withholding obligations in connection with the vesting of RSUs.

F1 · shares: This Form 4 corrects an error on the original Form 4 filed on February 22, 2023. The original Form 4 stated that the Reporting Person sold 1,244 shares of the Issuer's common stock to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. The Reporting Person sold 1,076 shares of the Issuer's common stock on February 17, 2023 to cover tax withholding obligations in connection with the vesting of RSUs.

F3 · price: This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: The error in the original Form 4 was carried through in Column 5 of Table 1 in subsequent filings but is corrected in the total amount of securities owned in this Form 4.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 16:45 UTC GrantRestricted Stock Units · Derivative 41,541 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-007484 · form4.xml · derivative · entry 2

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,541

Underlying: Common Stock · 41,541 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 16:45 UTC GrantStock Option (Right to Buy) · Derivative 124,496 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-007484 · form4.xml · derivative · entry 1

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,496

Underlying: Common Stock · 124,496 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This option represents a right to purchase a total of 124,496 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Militello JohnSee Remarks
GrantRestricted Stock Units · Derivative 16,616 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-007485 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,616

Underlying: Common Stock · 16,616 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Militello JohnSee Remarks
GrantStock Option (Right to Buy) · Derivative 49,798 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-007485 · form4.xml · derivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,798

Underlying: Common Stock · 49,798 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This option represents a right to purchase a total of 49,798 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Wilson MartinGeneral Counsel
GrantRestricted Stock Units · Derivative 29,079 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-007486 · form4.xml · derivative · entry 2

Wilson Martin · CIK 0001704342 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,079

Underlying: Common Stock · 29,079 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Wilson MartinGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 87,147 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-007486 · form4.xml · derivative · entry 1

Wilson Martin · CIK 0001704342 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,147

Underlying: Common Stock · 87,147 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This option represents a right to purchase a total of 87,147 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Shah GauravDirector · CEO
GrantRestricted Stock Units · Derivative 116,317 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-007482 · form4.xml · derivative · entry 2

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,317

Underlying: Common Stock · 116,317 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Shah GauravDirector · CEO
GrantStock Option (Right to Buy) · Derivative 348,590 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-007482 · form4.xml · derivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,590

Underlying: Common Stock · 348,590 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This option represents a right to purchase a total of 348,590 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Patel KinnariSee Remarks
GrantRestricted Stock Units · Derivative 66,467 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-007483 · form4.xml · derivative · entry 2

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,467

Underlying: Common Stock · 66,467 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 21:45 UTC
Patel KinnariSee Remarks
GrantStock Option (Right to Buy) · Derivative 199,194 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-007483 · form4.xml · derivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,194

Underlying: Common Stock · 199,194 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This option represents a right to purchase a total of 199,194 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 22, 2023 19:25 UTC Amendment Exercise / conversionRestricted Stock Units · Derivative 8,574 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008101 · form4.xml · derivative · entry 4

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,410

Underlying: Common Stock · 8,574 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F6 · derivative.expiration_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 22, 2023 19:25 UTC Amendment GrantRestricted Stock Units · Derivative 41,541 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008101 · form4.xml · derivative · entry 3

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,541

Underlying: Common Stock · 41,541 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F5 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 22, 2023 19:25 UTC Amendment GrantStock Option (Right to Buy) · Derivative 124,496 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-008101 · form4.xml · derivative · entry 2

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,496

Underlying: Common Stock · 124,496 shares

Expires 2033-02-13

F3 · derivative.exercise_date: This option represents a right to purchase a total of 124,496 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 22, 2023 19:25 UTC Amendment Exercise / conversionCommon Stock 8,574 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008101 · form4.xml · nonDerivative · entry 1

Schwartz Jonathan David · CIK 0001726398 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F2 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit award.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 2,858 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008099 · form4.xml · derivative · entry 4

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,803

Underlying: Common Stock · 2,858 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F6 · derivative.expiration_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Militello JohnSee Remarks
GrantRestricted Stock Units · Derivative 16,616 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008099 · form4.xml · derivative · entry 3

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,616

Underlying: Common Stock · 16,616 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F5 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Militello JohnSee Remarks
GrantStock Option (Right to Buy) · Derivative 49,798 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-008099 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,798

Underlying: Common Stock · 49,798 shares

Expires 2033-02-13

F3 · derivative.exercise_date: This option represents a right to purchase a total of 49,798 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Militello JohnSee Remarks
Exercise / conversionCommon Stock 2,858 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008099 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F2 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit award.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Patel KinnariSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 15,720 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008100 · form4.xml · derivative · entry 6

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,917

Underlying: Common Stock · 15,720 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F7 · derivative.exercise_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F7 · derivative.expiration_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Patel KinnariSee Remarks
GrantRestricted Stock Units · Derivative 66,467 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008100 · form4.xml · derivative · entry 5

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,467

Underlying: Common Stock · 66,467 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F6 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Patel KinnariSee Remarks
GrantStock Option (Right to Buy) · Derivative 199,194 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-008100 · form4.xml · derivative · entry 4

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,194

Underlying: Common Stock · 199,194 shares

Expires 2033-02-13

F4 · derivative.exercise_date: This option represents a right to purchase a total of 199,194 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Patel KinnariSee Remarks
Exercise / conversionCommon Stock 15,720 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008100 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F2 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit award.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Shah GauravDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 31,440 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008098 · form4.xml · derivative · entry 6

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,835

Underlying: Common Stock · 31,440 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F6 · derivative.expiration_date: One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Shah GauravDirector · CEO
GrantRestricted Stock Units · Derivative 116,317 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008098 · form4.xml · derivative · entry 5

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,317

Underlying: Common Stock · 116,317 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

F5 · derivative.expiration_date: One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Shah GauravDirector · CEO
GrantStock Option (Right to Buy) · Derivative 348,590 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-23-008098 · form4.xml · derivative · entry 4

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,590

Underlying: Common Stock · 348,590 shares

Expires 2033-02-13

F3 · derivative.exercise_date: This option represents a right to purchase a total of 348,590 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed Feb 23, 2023 00:25 UTC Amendment
Shah GauravDirector · CEO
Exercise / conversionCommon Stock 31,440 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-008098 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 549,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023.

F2 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit award.

Read SEC document
February 14, 2023 Filed Mar 26, 2024 00:54 UTC
Militello JohnSee Remarks
OtherRestricted Stock Units · Derivative 11,067 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-015101 · form4.xml · derivative · entry 9

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,903 shares

Expires not disclosed

F1 · security: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F2 · security: One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F1 · derivative.exercise_date: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F1 · derivative.expiration_date: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

Read SEC document
February 14, 2023 Filed Mar 26, 2024 00:54 UTC
Militello JohnSee Remarks
OtherCommon Stock 11,067 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-015101 · form4.xml · nonDerivative · entry 4

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,729

F1 · security: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F2 · security: One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F1 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

Read SEC document
February 14, 2023 Filed May 20, 2024 20:33 UTC
Shah GauravDirector · CEO
OtherRestricted Stock Units · Derivative 67,785 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-026878 · form4.xml · derivative · entry 11

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,947 shares

Expires not disclosed

F2 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F3 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F2 · derivative.exercise_date: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F2 · derivative.expiration_date: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed May 20, 2024 20:33 UTC
Shah GauravDirector · CEO
OtherCommon Stock 67,785 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-026878 · form4.xml · nonDerivative · entry 4

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 737,859

F2 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · security: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F3 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

Read SEC document
February 14, 2023 Filed May 20, 2024 20:29 UTC
Wilson MartinGeneral Counsel
OtherRestricted Stock Units · Derivative 16,947 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-026873 · form4.xml · derivative · entry 7

Wilson Martin · CIK 0001704342 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,947 shares

Expires not disclosed

F1 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F2 · security: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F1 · derivative.exercise_date: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F1 · derivative.expiration_date: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed May 20, 2024 20:29 UTC
Wilson MartinGeneral Counsel
OtherCommon Stock 16,947 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-026873 · form4.xml · nonDerivative · entry 3

Wilson Martin · CIK 0001704342 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,810

F1 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F2 · security: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F2 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

Read SEC document
February 14, 2023 Filed May 20, 2024 20:26 UTC
Patel KinnariSee Remarks
OtherRestricted Stock Units · Derivative 38,735 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-026871 · form4.xml · derivative · entry 13

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,735 shares

Expires not disclosed

F2 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F3 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F2 · derivative.exercise_date: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F2 · derivative.expiration_date: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
February 14, 2023 Filed May 20, 2024 20:26 UTC
Patel KinnariSee Remarks
OtherCommon Stock 38,735 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-026871 · form4.xml · nonDerivative · entry 5

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,018

F2 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · security: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

F3 · kind: Represents Restricted Stock Units ("RSUs") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.